TRIPLE VERSUS DUAL ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

被引：0
|
作者：
Hubin [1 ]
Zhouyujie [1 ]
Liuyuyang [1 ]
Shidongmei [1 ]
Zhaoyingxin [1 ]
Jiadean [1 ]
机构：
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China
来源：
HEART | 2011年 / 97卷
关键词：
D O I：
10.1136/heartjnl-2011-300867.554
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A novel de-escalation antiplatelet therapy for patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Li, Yachao
    Lei, Mengjie
    Yang, Yanli
    An, Lei
    Zhou, Haili
    Wang, Jingyao
    Zhao, Zhigang
    Wang, Xiangjin
    Nie, Shaoping
    Wang, Xiao
    Hau, William Kongto
    Xue, Zengming
    MEDICINE, 2023, 102 (27) : E34153
  • [22] DUAL ANTIPLATELET PLUS TIROFIBAN THERAPY HAVE A BENEFICIAL EFFECT ON ACUTE CORONARY SYNDROME IN DIABETIC PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Shen Hua
    Zhou Yujie
    Liu Yuyang
    Yang Shiwei
    Gao Fei
    Wang Zhijian
    Shi Dongmei
    Han Hongya
    Ge Hailong
    Liu Xiaoli
    HEART, 2010, 96 : A162 - A162
  • [23] A UK Time Trends Analysis of Dual Antiplatelet Therapy Use and Bleeding in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Mahadevan, Kalaivani
    Harris, Jessica
    Pufulete, Maria
    Johnson, Tom
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B392 - B392
  • [24] Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Bagai, Akshay
    Bhatt, Deepak L.
    Eikelboom, John W.
    Mancini, G. B. John
    Cohen, Eric A.
    Vijayaraghavan, Ram
    Cheema, Asim N.
    Udell, Jacob A.
    Niznick, Joel
    Tanguay, Jean-Francois
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 133 (21) : 2094 - 2098
  • [25] Optimal duration of dual antiplatelet therapy post percutaneous coronary intervention in acute coronary syndrome
    Deharo, Pierre
    Cuisset, Thomas
    TRENDS IN CARDIOVASCULAR MEDICINE, 2020, 30 (04) : 198 - 202
  • [26] Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
    Han, Jialun
    Zhang, Yi
    Shi, Xiujin
    Lin, Baidi
    Zhang, Yunnan
    Zhang, Ru
    Wang, Yifan
    Yan, Jialin
    Lin, Yang
    GLOBAL HEART, 2023, 18 (01)
  • [27] Optimizing antiplatelet therapy in acute coronary syndrome and percutaneous coronary intervention
    Faxon, David P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (02) : 181 - 197
  • [28] Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
    Agarwal, Nayan
    Jain, Ankur
    Mahmoud, Ahmed N.
    Bishnoi, Rohit
    Golwala, Harsh
    Karimi, Ashkan
    Mojadidi, Mohammad Khalid
    Garg, Jalaj
    Gupta, Tanush
    Patel, Nimesh Kirit
    Wayangankar, Siddharth
    Anderson, R. David
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (11): : 1280 - 1289
  • [29] Triple antiplatelet therapy decreases clopidogrel resistance in patients undergoing percutaneous coronary intervention
    Kim, W. J.
    Park, D. W.
    Lee, S. W.
    Kim, Y. K.
    Hong, M. K.
    Kim, J. J.
    Park, S. W.
    Park, S. J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 95C - 96C
  • [30] Triple Versus Dual Antiplatelet Therapy in Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention in the Era of Drug-Eluting Stent
    Chen, Kang-Yin
    Rha, Seung-Woon
    Li, Yong-Jian
    Podder, Kanhaiya
    Park, Jae Hyoung
    Na, Jin Oh
    Choi, Cheol Ung
    Lim, Hong Euy
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang gyu
    Seo, Hong Seog
    Oh, DongJoo
    Jeong, Myung Ho
    Ahn, YoungKeun
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 71I - 71I
12345